Takeda Pharmaceutical (TAK) Shares Outstanding (2017 - 2026)

Takeda Pharmaceutical has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $144.7 million in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) changed 0.02% year-over-year to $144.7 million in Q1 2026; TTM through Mar 2026 was $144.7 million, a 0.02% change from a year earlier, with the FY2026 full-year figure at $144.7 million, changed 0.02% from the prior year.
• Shares Outstanding (Entity) was $144.7 million for Q1 2026 at Takeda Pharmaceutical, roughly flat from $144.6 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $144.7 million in Q1 2026, with the low at $143.8 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $144.2 million, with a median of $143.9 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) increased 0.0% in 2023, then increased 0.54% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $143.8 million in 2022, then grew by 0.0% to $143.8 million in 2023, then rose by 0.01% to $143.9 million in 2024, then gained by 0.54% to $144.6 million in 2025, then increased by 0.02% to $144.7 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $144.7 million (Q1 2026), $144.6 million (Q1 2025), and $143.9 million (Q1 2024), per Business Quant data.